Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed1
Other1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT01510561Phase 1Withdrawn
A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.
Metastatic Pancreatic AdenocarcinomaMetastatic Pancreatic CancerPancreatic Cancer
StudychairStart date: 2012-03-01
NCT00421395Phase 1/2Completed
Safety Study of NHL With 90Y-hLL2 IgG
B-cell NHLNHLNon-Hodgkins Lymphoma
Studychair

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01510561Phase 1StudyChair

A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.

Metastatic Pancreatic AdenocarcinomaMetastatic Pancreatic CancerPancreatic Cancer
Withdrawn
NCT00421395Phase 1/2StudyChair

Safety Study of NHL With 90Y-hLL2 IgG

B-cell NHLNHLNon-Hodgkins Lymphoma
Completed

All 2 trials loaded